J. Goudsmit

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study (2009)

Maxfield, LF, King, SL, Riggs, AM, Dilan, R, LaPorte, A, Hural, J, ...

No abstract available.

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector (2009)

Baden, LR, Dolin, R, O'Brien, KL, Abbink, P, La Porte, A, Seaman, MS, ...

No abstract available.

Journal of General Virology (1997), 78, 2225–2233. Printed in Great Britain (2008)

Short Communication, J. Goudsmit

Evolution of human immunodeficiency virus subtype A in women seroconverting post partum and in their offspring post-natally infected by ingestion of breast milk

First Administration to Humans of a Monoclonal Antibody Cocktail Against Rabies Virus: Safety, Tolerability, and Neutralizing Activity (2008)

Bakker, A.B.H., Python, C., Kissling, C.J., Pandya, P., Marissen, W.E., Brink, M.F., ...

Immediate passive immune prophylaxis as part of rabies post-exposure prophylaxis (PEP) often cannot be provided due to limited availability of human or equine rabies immunoglobulin (HRIG and ERIG,...

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? (2005)

Leroy, V., Sakarovitch, C., Cortina-Borja, M., McIntyre, J., Coovadia, H., Dabis, F., ...

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities (2000)

Janssens, W, Zekeng, L, Musonda, R, Anagonou, S, ...

We developed a heteroduplex mobility assay in the gag gene (gag HMA) for the identification of group M subtypes A to H. The assay covers the region coding for amino acid 132 of p24 to amino acid 20...

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay (2000)

Janssens, W, Zekeng, L, Musonda, R, Anagonou, S, ...

We developed a heteroduplex mobility assay in the gag gene (gag HMA) for the identification of group M subtypes A to H. The assay covers the region coding for amino acid 132 of p24 to amino acid 20...

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. (2000)

HEYNDRICKX, L, JANSSENS, W, ZEKENG, L, MUSONDA, R, ANAGONOU, S, ...

Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo (2000)

De Baar, M. P., Janssens, W., De Ronde, A., Fransen, K., Colebunders, R., Kestens, L., ...

HIV-1 group O viruses were first recognized as a distinct subgroup of HIV-1 with the isolation and characterization in 1990 of a virus (ANT70) from a woman (individual A) and her spouse (individual...

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay (2000)

Heyndrickx, L., Janssens, W., Zekeng, L., Musonda, R., Anagonou, S., ...

We developed a heteroduplex mobility assay in the gag gene (gag HMA) for the identification of group M subtypes A to H. The assay covers the region coding for amino acid 132 of p24 to amino acid 20...

Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands (2000)

Goudsmit, J., Janssens, W., Heyndrickx, L., ...

Most HIV-1 subtype F viruses described so far have been isolated from individuals originating in South America, Romania, or Central Africa. Previous studies have shown that subtype F viruses from...

Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment (1997)

Jong, M.D. De, Boer, R.J. De, Wolf, F. De, Foudraine, N.A., Boucher, C.A.B., Goudsmit, J., ...

To determine whether, as predicted by predator-prey dynamics, early withdrawal of antiretroviral therapy, i.e. when the number of CD4+ lymphocytes is still elevated, results in an overshoot of HIV-1...

Fractionation of nucleic acids into single-stranded and double-stranded forms (1996)

Beld, M, Sol, C, Goudsmit, J, Boom, R

Fine specificity of antibody recognition may predict amino acid substitution in the third variable region of gp 120 during HIV type 1 infection (1995)

Langedijk, J.P.M., Zwart, G., Goudsmit, J., Meloen, R.H.

Virus load in chimpanzees infected with human-immunodeficiency-virus type-1 - effect of preexposure vaccination (1995)

Tenhaaft, P, Cornelissen, M, Goudsmit, J, Koornstra, W, Dubbes, R, Niphuis, H, ...

Many reports indicate that a long-term asymptomatic state following human immunodeficiency virus type I (HIV-1) infection is associated with a low amount of circulating virus. To evaluate the...

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

Baden, LR, Dolin, R, O'Brien, KL, Abbink, P, La Porte, A, Seaman, MS, ...

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study

Maxfield, LF, King, SL, Riggs, AM, Dilan, R, LaPorte, A, Hural, J, ...